China National Medicines Corporation Ltd.

SHSE:600511 Voorraadrapport

Marktkapitalisatie: CN¥24.0b

China National Medicines Beheer

Beheer criteriumcontroles 0/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Guotao Tian

Algemeen directeur

CN¥2.6m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO2.5yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn1.9yrs
Gemiddelde ambtstermijn bestuur2.6yrs

Recente managementupdates

Recent updates

The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 25
The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Sep 26
China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Sep 10
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

Jul 28
Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

Jun 24
China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Jun 07
China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Is China National Medicines (SHSE:600511) Using Too Much Debt?

Jun 05
Is China National Medicines (SHSE:600511) Using Too Much Debt?

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

May 21
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

Apr 10
Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

China National Medicines (SHSE:600511) Could Easily Take On More Debt

Feb 28
China National Medicines (SHSE:600511) Could Easily Take On More Debt

CEO

Guotao Tian (53 yo)

2.5yrs

Tenure

CN¥2,550,000

Compensatie

Mr. Guotao Tian is GM & Director of China National Medicines Corporation Ltd. from April 07, 2022.


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Guotao Tian
GM & Director2.5yrsCN¥2.55mgeen gegevens
Fei Chen
Chief Financial Officer1.1yrsCN¥191.30kgeen gegevens
Lichun Luo
Board Secretary2.5yrsCN¥1.15mgeen gegevens
Zhang Ting
Deputy Secretary of the Party Committeeno dataCN¥371.90kgeen gegevens

1.9yrs

Gemiddelde duur

46yo

Gemiddelde leeftijd

Ervaren management: 600511's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Guotao Tian
GM & Director2.6yrsCN¥2.55mgeen gegevens
Xiuchang Jiang
Chairman13.7yrsgeen gegevensgeen gegevens
Yong Liu
Director12.9yrsgeen gegevensgeen gegevens
Jingyun Liu
Chairman of the Supervisory Board12.9yrsgeen gegevensgeen gegevens
Luwen Shi
Independent Director2.6yrsCN¥200.00kgeen gegevens
Xingxi Yu
Independent Director2.6yrsCN¥200.00kgeen gegevens
Deyong Wen
Director5.5yrsgeen gegevensgeen gegevens
Xin Jiang
Director2.6yrsCN¥2.55mgeen gegevens
Xiaojuan Li
Director2.6yrsgeen gegevensgeen gegevens
Kai Lu
Supervisor2.6yrsgeen gegevensgeen gegevens

2.6yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren bestuur: 600511's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.